-
Mashup Score: 1Columbia Restaurant · 2117 E 7th Ave, Tampa, FL 33605 - 10 month(s) ago
4.5 ★ · Spanish restaurant
Source: www.google.com.mxCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Real-World Database Studies in Oncology: A Call for Standards - 10 month(s) ago
Real-world data (RWD), the data relating to patient health status and routinely collected in the delivery of health care, can provide critical evidence about care and outcomes across the cancer continuum. When analyzed using rigorous methods, RWD can address a number of important questions that are not practical, feasible, or ethical to address with clinical trials. This important advantage of RWD is also a limitation, namely, what is captured in real-world databases reflects the observed experiences,
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
RT @JulioChavezMD: Towards standardization of RWE studies. Much needed article https://t.co/zDHdZJveIG
-
-
Mashup Score: 1
Humans show strong sex differences in immunity to infection and autoimmunity, suggesting sex hormones modulate immune responses. Indeed, receptors for estrogens (ERs) regulate cells and pathways in the innate and adaptive immune system, as well as immune cell development. ERs are ligand-dependent tr …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
@majorajay @VeitBuecklein @KRejeski @gloria_iacoboni Could be… some rol of sex hormones? And the answer … YES. Estrogen receptors are involve in epigenetic pathways. Estradiol and ER activity show profound dose- and context-dependent effects on innate immune signaling pathways. https://t.co/I8Jl0sXRt2
-
-
Mashup Score: 0Samuel García regresará a como gobernador, el 1o de diciembre se va: Ramón Alberto Garza #Entrevista - 1 year(s) ago
Ramón Alberto Garza, director general Código Magenta, en entrevista con José Cárdenas, explico que, en medio de las precampañas por la Presidencia de la Repú…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
Y quien dirá la verdad? @CodigoMagentaMx o @samuel_garcias alias “el nuevo”? Interesante el desmother en Nuevo León. “El pueblo Neoleonés votó por mi…” si, para que te quedarás 6 años. @AlvarezMaynez danos tu opinión de esta entrevista? https://t.co/WLOeYCyZNT https://t.co/7PEk0sMHEo
-
-
Mashup Score: 3
Harnessing all the available immunohistochemical data without reliance on the order of examination or cut-off value, we conclude that our PV machine learning algorithm outperforms Hans and other IHC-decision tree algorithms currently in use and represents an affordable and time-saving alternative fo …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
Here, the references. If we start with FOXP1 and GCET1 we would get no-GC/ABC identify. Then we could try personalized the treatment, where GC can try to be salvage with DHAP + ASCT and non-GC polatuzumab plus chemo (i.e. ICE) + ASCT. https://t.co/AmnFhN8Vvy https://t.co/vDg39yHFl2
-
-
Mashup Score: 1Multiparameter prediction of myeloid neoplasia risk - 1 year(s) ago
Nature Genetics – An analysis of UK Biobank participants shows that the risk of developing different types of myeloid neoplasms can be inferred years before diagnosis. The authors integrate somatic…
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @PathologyPat: Multiparameter prediction of myeloid neoplasia risk | Nature Genetics https://t.co/TtXiiEpLSR
-
-
Mashup Score: 6
The FDA has granted accelerated approval to elranatamab-bcmm (Elrexfio) for the treatment of adult patients with relapsed or refractory multiple myeloma who have previously received at least 4 lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.
Source: www.onclive.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @OncLive: BREAKING: @US_FDA Approves Elranatamab for Relapsed or Refractory Multiple Myeloma #mmsm #oncology https://t.co/pLHvmmjEr8 htt…
-
-
Mashup Score: 0Please wait whilst we redirect you - 2 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Treatment and survival in very elderly DLBCL patient. You can see our paper in this link https://t.co/svEaJrRacm
-
-
Mashup Score: 12
The European LeukemiaNet recently revised both the clinical (2022) and measurable residual disease testing (2021) guidelines for acute myeloid leukemi…
Source: www.sciencedirect.comCategories: Hematologists1, Latest HeadlinesTweet-
RT @Dr_AmerZeidan: How I treat AML incorporating the updated classifications and guidelin... https://t.co/cSqs5zDdFF
-
-
Mashup Score: 0
In Latin America, the same treatment regimens are used as in highly developed countries, although we lack the necessary technology to apply CAR T-cell therapies or a network of trials sponsored by the pharmaceutical industry.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
@DrMCanales talking about bendamustine in DLBCL. Let me add our paper (Villela L hematology 2023) where we showed different treatment in patients >80y. https://t.co/uWXV6jWozC https://t.co/auvZX1LRw4
-
@AaronGoodman33 Columbia Restaurant +1 813-248-4961 https://t.co/mglbUxyJ2t